Immunogenicity 10739
Sample ID
3678
Response
Negative
Tumor Type
Melanoma
Gene Symbol
ADD1
Transcript ID
None
HLA INFO
B*44:02
TCR INFO
No TCR info found!
Full length protein sequence (799 aa)
MNGDS
1
RAAVV
6
TSPPP
11
TTAPH
16
KERYF
21
DRVDE
26
NNPEY
31
LRERN
36
MAPDL
41
RQDFN
46
MMEQK
51
KRVSM
56
ILQSP
61
AFCEE
66
LESMI
71
QEQFK
76
KGKNP
81
TGLLA
86
LQQIA
91
DFMTT
96
NVPNV
101
YPAAP
106
QGGMA
111
ALNMS
116
LGMVT
121
PVNDL
126
RGSDS
131
IAYDK
136
GEKLL
141
RCKLA
146
AFYRL
151
ADLFG
156
WSQLI
161
YNHIT
166
TRVNS
171
EQEHF
176
LIVPF
181
GLLYS
186
EVTAS
191
SLVKI
196
NLQGD
201
IVDRG
206
STNLG
211
VNQAG
216
FTLHS
221
AIYAA
226
RPDVK
231
CVVHI
236
HTPAG
241
AAVSA
246
MKCGL
251
LPISP
256
EALSL
261
GEVAY
266
HDYHG
271
ILVDE
276
EEKVL
281
IQKNL
286
GPKSK
291
VLILR
296
NHGLV
301
SVGES
306
VEEAF
311
YYIHN
316
LVVAC
321
EIQVR
326
TLASA
331
GGPDN
336
LVLLN
341
PEKYK
346
AKSRS
351
PGSPV
356
GEGTG
361
SPPKW
366
QIGEQ
371
EFEAL
376
MRMLD
381
NLGYR
386
TGYPY
391
RYPAL
396
REKSK
401
KYSDV
406
EVPAS
411
VTGYS
416
FASDG
421
DSGTC
426
SPLRH
431
SFQKQ
436
QREKT
441
RWLNS
446
GRGDE
451
ASEEG
456
QNGSS
461
PKSKT
466
KVWTN
471
ITHDH
476
VKPLL
481
QSLSS
486
GVCVP
491
SCITN
496
CLWTK
501
EDGHR
506
TSTSA
511
VPNLF
516
VPLNT
521
NPKEV
526
QEMRN
531
KIREQ
536
NLQDI
541
KTAGP
546
QSQVL
551
CGVVM
556
DRSLV
561
QDAPL
566
SDCTE
571
TIEGL
576
ELTEQ
581
TFSPA
586
KSLSF
591
RKGEL
596
VTASK
601
AIIEK
606
EYQPH
611
VIVST
616
TGPNP
621
FTTLT
626
DRELE
631
EYRRE
636
VERKQ
641
KGSEE
646
NLDEA
651
REQKE
656
KSPPD
661
QPAVP
666
HPPPS
671
TPIKL
676
EEDLV
681
PEPTT
686
GDDSD
691
AATFK
696
PTLPD
701
LSPDE
706
PSEAL
711
GFPML
716
EKEEE
721
AHRPP
726
SPTEA
731
PTEAS
736
PEPAP
741
DPAPV
746
AEEAA
751
PSAVE
756
EGAAA
761
DPGSD
766
GSPGK
771
SPSKK
776
KKKFR
781
TPSFL
786
KKSKK
791
KSDS
796
Mutation Information
DNA mutation:
None
Peptide Range:
56 ~ 80
Mut AA position:
68 (13 in Wild Type peptide)
Alignment
Wild Type:
"KRVSMILQSPAFCEELESMIQEQFK
||||||||||||.||||||||||||
Mutant:
KRVSMILQSPAFWEELESMIQEQFK"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) ADD1
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
ELISPOT assay